Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism

Pigment Cell Research

Volumn 16, Issue 5, 2003, Pages 494-500

  Nakamura, Kyoko ^a   Yoshida, Masaki ^a   Uchiwa, Hideyo ^a   Kawa, Yoko ^b   Mizoguchi, Masako ^b  

^a KANEBO LTD   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Degradation; Maturation; Melanocytes; Melanogenesis; Tyrosinase

Indexed keywords

2,2' DIHYDROXY 5,5' DIPROPYLBIPHENYL; ARBUTIN; BIPHENYL DERIVATIVE; GLYCOPROTEIN GP 100; HYDROQUINONE; KOJIC ACID; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MELANIN; MEMBRANE PROTEIN; MONOPHENOL MONOOXYGENASE; PHENOL DERIVATIVE; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; MELANOSOME; MOUSE; MUSHROOM; NONHUMAN; PIGMENT DISORDER; PROTEIN SYNTHESIS; REACTION ANALYSIS; WESTERN BLOTTING;

ANIMALS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MELANINS; MELANOCYTES; MELANOMA; MICE; MOLECULAR STRUCTURE; MONOPHENOL MONOOXYGENASE; PHENOLS; PROTEIN SYNTHESIS INHIBITORS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

ANIMALIA; BASIDIOMYCOTA;

EID: 0042337124     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2003.00084.x     Document Type: Article

References (22)

1. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994;20: 592-597
2. Sanchez IL, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol 1982;21: 55-58
3. Hearing VJ. Mammalian monophenol monooxygenase (tyrosinase):purification properties and reactions catalyzed. Meth Enzymol 1987;142: 154-165
4. Hearing VJ, Jiménez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989;2: 75-85
5. Sartori G, Maggi R, Bigi F, Arienti A, Casnati G. Oxidative coupling of dichloroaluminium phenolates: highly selective synthesis of hydroxylated bi- and tetraaryls. Tetrahedron 1992;48: 9483-9494
6. Ando H, Funasaka Y, Oka M, Ohashi A, Furumura M, Matsunaga J, Matsunaga N, Hearing VJ, Ichihashi M. Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis. J Lipid Res 1999;40: 1312-1316
7. Napolitano A, Palumbo A, d'Ischia M, Prota G. Mechanism of selective incorporation of the melanoma seeker 2-thiouracil into growing melanin. J Med Chem 1996;39: 5192-5201
8. Imokawa G, Yada Y, Okuda M. Allergic contact dermatitis releases soluble factors that stimulate melanogenesis through activation of protein kinase C-related signal-transduction pathway. J Invest Dermatol 1992;99: 482-488
9. Pomerantz SH. Separation, purification, and properties of two tyrosinases from hamster melanoma. J Biol Chem 1963;238: 2351-2357
10. Seiji M, Shimao K, Birbeck MSC, Fitzpatrick TB. Subcellular localization of melanin biosynthesis. Ann NY Acad Sci 1963;100: 497-533
11. Potterf SB, Muller J, Bernardini I, Tietze F, Kobayashi T. Hearing VJ, Gahl WA. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine. J Biol Chem 1996;271: 4002-4008
12. Pomerantz SH. The tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem 1966;241: 161-168
13. 3H]tyrosine in cell-free extracts and tissue cultures of melanoma cells: a new assay method for tyrosinase in living cells. Arch Biochem Biophys 1972;148: 548-557
14. Sasaki M, Horikoshi T, Uchiwa H, Miyachi Y. Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res 2000;13: 248-252
15. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds). Metabolic labeling with amino acids. In: Current Protocols in Molecular Biology, Vol. 2. New York: John Wiley & Sons Inc., 1998:10-18
16. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds). Immunoprecipitation. Current Protocols in Molecular Biology, Vol. 2. New York: John Wiley & Sons, Inc., 1998; 10-16
17. Toyofuku K, Wada I, Spritz RA, Hearing VJ. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Biochem J 2001;355: 259-269
18. Halaban R, Cheng E, Zhang Y, Moellmann G, Hanlon D, Michalak M, Setaluri V, Hebert DN. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelnanotic melanoma cells. Proc Natl Acad Sci USA 1997;94: 6210-6215
19. Jimbow K, Park JS, Kato F, Hirosaki K, Toyofuku K, Hua C, Yamashita T. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Res 2000;13: 222-229
20. Branza-Nichita N, Petrescu AJ, Dwek RA, Wormald MR, Platt FM, Petrescu SM. Tyrosinase folding and copper loading in vivo: a crucial role for calnexine and α-glucosidase II. Biochem Biophys Res Commun 1999;261: 720-725
21. Clinical trial group for linoleic acid-containing gel. Clinical trial for liver spots using a linoleic acid-containing gel. Nishinihon J Dermatol 1998;60: 537-542
22. Halaban R, Cheng E, Svedine S, Aron R, Hebert DN. Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine. J Biol Chem 2001;276:11933-11938